It's never too early, or too late, to start thinking about managing the life cycle of exclusivity and getting the most value from your discoveries . In this networking seminar, we will share real-life case studies and provide practical advice on maximizing the scope and duration of patent protection for your drug or clinical candidate in both the US and Europe.
Join us on April 23rd at the Café ArtScience in Cambridge, MA to hear panelists Emily Hayes and Sarah Kostiuk-Smith from Mewburn Ellis and Hunter Baker and Dan Young from Wolf Greenfield compare and contrast the patent strategies available to build a robust patent portfolio.
Find out more about the event here.
In our new magazine Forward, we interview C Hunter Baker of Wolf, Greenfield & Sacks PC. In his article Playing for time: strategies that can help extend a drug's patent life Hunter explores a typical drug development timeline and suggests strategies that can help extend a drug's patent life.